Active — Not RecruitingNot Applicable

Retinal Pigment Epithelium Safety Study for Patients in B4711001

United Kingdom10 participantsStarted 2024-04-16

Plain-language summary

This is a safety follow-up study. Patients enrolled in B4711001 will be followed for a further 4 years with regular visits to assess safety.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Previous participation in Protocol B4711001 and received treatment with PF-05206388. * Subjects who are willing and able to comply with scheduled visits, and study procedures. Exclusion Criteria: * there are no exclusion criteria

What they're measuring

incidence of serious adverse events and ocular adverse events

Timeframe: 4 years

Trial details

NCT IDNCT03102138

SponsorMoorfields Eye Hospital NHS Foundation Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-05-30

View on ClinicalTrials.gov More Age Related Macular Degeneration trials